Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

This study has been completed.

Study NCT00441090 Information provided by Eisai Inc.

First Received: February 27, 2007 Last Updated: November 14, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)